Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study
Authors
Keywords
Hodgkin disease, Indoleamine-pyrrole 2,3-dioxygenase, Macrophages, Stromal cells, Tumor microenvironment, Epstein-barr virus infections, Pathology
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-05-16
DOI
10.1186/1471-2407-14-335
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hodgkin Disease and the Role of the Immune System
- (2016) Alana A. Kennedy-Nasser et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Impact of the Epstein–Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea
- (2012) Young Wha Koh et al. ANNALS OF HEMATOLOGY
- The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase
- (2012) Mads Hald Andersen CANCER IMMUNOLOGY IMMUNOTHERAPY
- Expression of FOXP3, CD68, and CD20 at Diagnosis in the Microenvironment of Classical Hodgkin Lymphoma Is Predictive of Outcome
- (2012) Paul Greaves et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of the noncanonical NF- B pathway by HIV controls a dendritic cell immunoregulatory phenotype
- (2012) O. Manches et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T lymphocytes to IDO+ cells: check
- (2011) C. M. Wilke et al. BLOOD
- Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
- (2011) J. Godin-Ethier et al. CLINICAL CANCER RESEARCH
- IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway
- (2011) Hyunkeun Song et al. IMMUNOLOGY LETTERS
- Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
- (2011) Christian Steidl et al. JOURNAL OF CLINICAL ONCOLOGY
- Refined Prognostic Role of CD68-Positive Tumor Macrophages in the Context of the Cellular Micromilieu of Classical Hodgkin Lymphoma
- (2011) Alexandar Tzankov et al. PATHOBIOLOGY
- Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma
- (2011) Mona A. A. Zaki et al. VIRCHOWS ARCHIV
- Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP
- (2010) Soranobu Ninomiya et al. ANNALS OF HEMATOLOGY
- Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma
- (2010) P. Kamper et al. HAEMATOLOGICA
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
- (2010) Christian Steidl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma
- (2009) Tomoko Inaba et al. GYNECOLOGIC ONCOLOGY
- The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology
- (2008) A. Curti et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now